Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nat Med. 2022 Oct;28(10):2133-2144. doi: 10.1038/s41591-022-02003-x. Epub 2022 Sep 29.
Trogocytosis is an active process that transfers surface material from targeted to effector cells. Using multiple in vivo tumor models and clinical data, we report that chimeric antigen receptor (CAR) activation in natural killer (NK) cells promoted transfer of the CAR cognate antigen from tumor to NK cells, resulting in (1) lower tumor antigen density, thus impairing the ability of CAR-NK cells to engage with their target, and (2) induced self-recognition and continuous CAR-mediated engagement, resulting in fratricide of trogocytic antigen-expressing NK cells (NK) and NK cell hyporesponsiveness. This phenomenon could be offset by a dual-CAR system incorporating both an activating CAR against the cognate tumor antigen and an NK self-recognizing inhibitory CAR that transferred a 'don't kill me' signal to NK cells upon engagement with their TROG siblings. This system prevented trogocytic antigen-mediated fratricide, while sparing activating CAR signaling against the tumor antigen, and resulted in enhanced CAR-NK cell activity.
细胞融合是一种将靶细胞表面物质转移到效应细胞的主动过程。本研究使用多种体内肿瘤模型和临床数据表明,嵌合抗原受体(CAR)在自然杀伤(NK)细胞中的激活促进了 CAR 同源抗原从肿瘤向 NK 细胞的转移,导致(1)肿瘤抗原密度降低,从而削弱了 CAR-NK 细胞与靶细胞结合的能力,(2)诱导自身识别和连续的 CAR 介导的结合,导致表达 CAR 的 NK 细胞(NK)的细胞融合和 NK 细胞低反应性。通过双重 CAR 系统可以克服这种现象,该系统同时包含针对同源肿瘤抗原的激活 CAR 和 NK 自身识别抑制性 CAR,当与 NK 细胞的“TROG”兄弟结合时,抑制性 CAR 向 NK 细胞传递“不要杀死我”的信号。该系统防止了 trogocytic 抗原介导的细胞融合,同时保留了针对肿瘤抗原的激活 CAR 信号,从而增强了 CAR-NK 细胞的活性。
Mol Cancer. 2023-11-16
J Transl Genet Genom. 2023-12-5
J Immunother Cancer. 2024-2-27
Int J Mol Sci. 2025-6-29
Front Med (Lausanne). 2025-6-25
Breast Cancer. 2025-6-23
Oncologist. 2025-6-4
Front Immunol. 2025-5-27
Cell. 2021-12-9
Oncogene. 2021-1
Nat Rev Clin Oncol. 2021-2
Infect Immun. 2020-6-22